http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-032432-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00cf135003c69ae281b696d3bc73e0c9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
filingDate 2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7894ab004cde0f8b558f98918238f614
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_952553f7a89bdccecfe797a2917e848c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a79573fe6af93b306a79395cc391a109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b63a96ed0a42bbde95cae5061900c3e
publicationDate 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EA-032432-B1
titleOfInvention SPECIFIC ANALOGUE OF TRIFLUORETHYLTRINOCHINOLINE FOR APPLICATION IN THE TREATMENT OF CHEBRENE SYNDROME
abstract The application describes N - {(R) -1- [8-chloro-2- (1-hydroxypyridin-3-yl) quinolin-3-yl] -2,2,2-trifluoroethyl} pyrido [3,2-d ] pyrimidine-4-ylamine, which is effective in the treatment and / or prevention of Sjogren's syndrome.
priorityDate 2015-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012032334-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414809476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457494048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12734305
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501665

Total number of triples: 35.